New Drug Applications

FDA Accepts Evoke Pharma’s NDA Resubmission for Gimoti

6 years ago
by David Miller
950 Views
Written by David Miller

SOLANA BEACH, Calif., Jan. 21, 2020 (GLOBE NEWSWIRE) — Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on the development of drugs to treat gastrointestinal (GI) disorders and diseases, today…Original Article

You may also like

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts
[mwai_chat window="true" fullscreen="true"]